410 related articles for article (PubMed ID: 29695183)
1. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
Sudha MR; Jayanthi N; Aasin M; Dhanashri RD; Anirudh T
Benef Microbes; 2018 Jun; 9(4):563-572. PubMed ID: 29695183
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults.
Madempudi RS; Ahire JJ; Neelamraju J; Tripathi A; Nanal S
Sci Rep; 2019 Aug; 9(1):12210. PubMed ID: 31434935
[TBL] [Abstract][Full Text] [Related]
3. Bacillus coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study.
Madempudi RS; Neelamraju J; Ahire JJ; Gupta SK; Shukla VK
Probiotics Antimicrob Proteins; 2020 Jun; 12(2):335-342. PubMed ID: 30911991
[TBL] [Abstract][Full Text] [Related]
4. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
Majeed M; Nagabhushanam K; Natarajan S; Sivakumar A; Ali F; Pande A; Majeed S; Karri SK
Nutr J; 2016 Feb; 15():21. PubMed ID: 26922379
[TBL] [Abstract][Full Text] [Related]
5. Effect of Bacillus coagulans Unique IS2 with Lactulose on Functional Constipation in Adults: a Double-Blind Placebo Controlled Study.
Venkataraman R; Shenoy R; Ahire JJ; Neelamraju J; Madempudi RS
Probiotics Antimicrob Proteins; 2023 Apr; 15(2):379-386. PubMed ID: 34599466
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
Gupta AK; Maity C
Medicine (Baltimore); 2021 Jan; 100(3):e23641. PubMed ID: 33545934
[TBL] [Abstract][Full Text] [Related]
7. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
Urgesi R; Casale C; Pistelli R; Rapaccini GL; de Vitis I
Eur Rev Med Pharmacol Sci; 2014; 18(9):1344-53. PubMed ID: 24867512
[TBL] [Abstract][Full Text] [Related]
8. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
Xie P; Luo M; Deng X; Fan J; Xiong L
Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686889
[TBL] [Abstract][Full Text] [Related]
9. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
Hun L
Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
[TBL] [Abstract][Full Text] [Related]
10. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome.
Dolin BJ
Methods Find Exp Clin Pharmacol; 2009 Dec; 31(10):655-9. PubMed ID: 20140275
[TBL] [Abstract][Full Text] [Related]
11. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
Abhari K; Saadati S; Hosseini-Oskouiee F; Yari Z; Hosseini H; Sohrab G; Hejazi E; Agah S; Sadeghi A; Hekmatdoost A
Eur J Nutr; 2020 Aug; 59(5):2111-2117. PubMed ID: 31327047
[TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
Pineton de Chambrun G; Neut C; Chau A; Cazaubiel M; Pelerin F; Justen P; Desreumaux P
Dig Liver Dis; 2015 Feb; 47(2):119-24. PubMed ID: 25488056
[TBL] [Abstract][Full Text] [Related]
13. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
[TBL] [Abstract][Full Text] [Related]
15. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
16. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing
Skrzydło-Radomańska B; Prozorow-Król B; Kurzeja-Mirosław A; Cichoż-Lach H; Laskowska K; Majsiak E; Bierła JB; Agnieszka S; Cukrowska B
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510953
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
18. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
19. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
Ringel-Kulka T; McRorie J; Ringel Y
Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
[TBL] [Abstract][Full Text] [Related]
20. A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort.
Maity C; Gupta AK
Eur J Clin Pharmacol; 2019 Jan; 75(1):21-31. PubMed ID: 30264164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
